New model predicts Barrett's oesophagus recurrence
Dutch clinicians say their tool can help guide individualised post-treatment surveillance based on patient risk
A new model that predicts visible recurrence after endoscopic eradication of Barrett's oesophagus with dysplasia or early cancer can help establish a personalised follow-up strategy for patients, researchers say.
The prognostic model, which has been externally validated, was built using data from adults in the Dutch Barrett Expert Center Registry who underwent endoscopic treatment.
“Once complete Barrett's eradication is achieved, the chances for neoplastic recurrence are so small that we significantly
